The Biliary Tract Cancer Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the biliary tract cancer market has been expanding robustly over time. From 2024 to 2025, the market is projected to grow from $0.67 billion to $0.72 billion, indicating a compound annual growth rate (CAGR) of 7.5%.
By 2029, the global market for biliary tract cancer is projected to reach $0.95 billion, expanding at a compound annual growth rate (CAGR) of 7.3%.
Download Your Free Sample of the 2025 Biliary Tract Cancer Market Report and Uncover Key Trends Now!The key drivers in the biliary tract cancer market are:
• Lifestyle changes leading to increased incidence of biliary tract cancer
• Growing awareness and early detection initiatives
• Favorable reimbursement policies and supportive government policies
• Technological advancements in diagnosis, treatment, and biomarker-based therapies.
The biliary tract cancer market covered in this report is segmented –
1) By Cancer Type: Intrahepatic Bile Duct Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer
2) By Treatment: Chemotherapy, Targeted Therapy, Immunotherapy
3) By End-User: Hospitals, Specialty Cancer Centres, Ambulatory Surgical Centres, Other End-Users
Subsegments:
1) By Intrahepatic Bile Duct Cancer: Peripheral Intrahepatic Bile Duct Cancer, Hilar Intrahepatic Bile Duct Cancer
2) By Extrahepatic Bile Duct Cancer: Perihilar Bile Duct Cancer, Distal Bile Duct Cancer
3) By Gallbladder Cancer: Localized Gallbladder Cancer, Advanced Gallbladder Cancer
The key trends in the biliary tract cancer market are:
• Technological advancements in diagnosis and treatment are emerging as a crucial trend.
• Adoption of immunotherapy in treating biliary tract cancer is becoming increasingly prevalent.
• There is a surging demand for precision medicine in the market.
• Evolving treatment methods and the development of biomarker-based therapies are notable trends.
Major players in the biliary tract cancer market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• AstraZeneca Plc
• Eli Lily and Company
• Boehringer Ingelheim International GmbH
• Eisai Co. Ltd.
• Servier Pharmaceuticals
• Jazz Pharmaceuticals plc
• Incyte Corporation
• BeiGene LTD.
• Zymeworks
• Basilea Pharmaceutica Ltd.
• Taiho Oncology Inc.
• RenovoRx Inc.
• TransThera Sciences Inc.
• QED Therapeutics Inc.
• Helsinn Group
North America was the largest region in the biliary tract cancer market in 2024